Purdue Pharma has filed a new bankruptcy plan, aiming to finalize a $7.4 billion opioid settlement after its previous attempt was derailed..
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.